Merypat Sachet

The sachet formulation allows for convenient oral administration, typically dissolved in water before ingestion. Dosage and duration of treatment should be individualized based on serum potassium levels and clinical response, under the guidance of a healthcare professional. Common side effects may include gastrointestinal disturbances such as constipation, nausea, or mild abdominal discomfort.

It is contraindicated in patients with hypocalcemia, bowel obstruction, or known hypersensitivity to the active ingredient. Caution is advised when used concomitantly with other medications that affect electrolyte balance. Regular monitoring of serum electrolytes is essential during therapy to avoid complications such as hypokalemia or hypercalcemia. Merypat Sachet is a valuable therapeutic agent in managing hyperkalemia and maintaining electrolyte homeostasis.